BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 14278168)

  • 1. THE INITIATION AND ENHANCEMENT OF HUMAN RED CELL LYSIS BY ACTIVATORS OF THE FIRST COMPONENT OF COMPLEMENT AND BY FIRST COMPONENT ESTERASE; STUDIES USING NORMAL RED CELLS AND RED CELLS FROM PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.
    YACHNIN S; RUTHENBERG JM
    J Clin Invest; 1965 Apr; 44(4):518-34. PubMed ID: 14278168
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of streptokinase, epinephrine and plasmin on the paroxysmal nocturnal hemoglobinuria serum hemolytic system.
    AUDITORE JV
    J Appl Physiol; 1960 Mar; 15():275-9. PubMed ID: 13795055
    [No Abstract]   [Full Text] [Related]  

  • 3. THE ACTION OF TWO SULFHYDRYL COMPOUNDS ON NORMAL HUMAN RED CELLS. RELATIONSHIP TO RED CELLS OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.
    SIRCHIA G; FERRONE S; MERCURIALI F
    Blood; 1965 Apr; 25():502-10. PubMed ID: 14284339
    [No Abstract]   [Full Text] [Related]  

  • 4. STUDIES ON THE RESISTANCE OF RED BLOOD CELLS TO THE HEMOLYTIC ACTION OF DISTREPTASE (STREPTOKINASE + STREPTODORNASE).
    HANKIEWICZ J
    Arch Immunol Ther Exp (Warsz); 1964; 12():534-41. PubMed ID: 14247378
    [No Abstract]   [Full Text] [Related]  

  • 5. Properdin Is a Key Player in Lysis of Red Blood Cells and Complement Activation on Endothelial Cells in Hemolytic Anemias Caused by Complement Dysregulation.
    Chen JY; Galwankar NS; Emch HN; Menon SS; Cortes C; Thurman JM; Merrill SA; Brodsky RA; Ferreira VP
    Front Immunol; 2020; 11():1460. PubMed ID: 32793201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. THE HEMOLYSIS OF RED CELLS FROM PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA BY PARTIALLY PURIFIED SUB-COMPONENTS OF THE THIRD COMPLEMENT COMPONENT.
    YACHNIN S
    J Clin Invest; 1965 Sep; 44(9):1534-46. PubMed ID: 14332166
    [No Abstract]   [Full Text] [Related]  

  • 7. The properdin system and immunity. IV. The hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria.
    HINZ CF; JORDAN WS; PILLEMER L
    J Clin Invest; 1956 May; 35(5):453-7. PubMed ID: 13319478
    [No Abstract]   [Full Text] [Related]  

  • 8. Paroxysmal nocturnal hemoglobinuria. Alternate-complement-pathway-mediated lysis induced by magnesium.
    May JE; Rosse W; Frank MM
    N Engl J Med; 1973 Oct; 289(14):705-9. PubMed ID: 4727529
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influencing of properidin activity by erythrocyte stroma, with a contribution to hemolysis problem in paroxysmal nocturnal hemoglobinuria: Marchiafava-Micheli anemia].
    MARTIN H; VOSS J
    Vox Sang; 1957 Jul; 2(3):201-17. PubMed ID: 13468368
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE ETIOLOGY OF NOCTURNAL PAROXYSMAL HEMOGLOBINURIA OF THE MARCHIAFAVA TYPE AND OTHER HEMOLYTIC ANEMIAS AND THEIR RELATION TO ERYTHROCYTE ENZYMAS].
    MEYER A
    Ther Umsch; 1963 Nov; 20():546-55. PubMed ID: 14101320
    [No Abstract]   [Full Text] [Related]  

  • 11. [ Complement activation by the alternate pathway (or properdin pathway) in paroxysmal nocturnal hemoglobinuria].
    Audran R
    Rev Fr Transfus; 1974 Dec; 17(4):333-48. PubMed ID: 4464553
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of ionic strength upon hemolysis of paroxysmal nocturnal hemoglobinuria erythrocytes.
    Yachnin S
    Proc Soc Exp Biol Med; 1965 Dec; 120(3):715-8. PubMed ID: 5858695
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of properdin, O degree factor, polyinosinic acid, and thrombin in the haemolysis of paroxysmal nocturnal haemoglobinuria erythrocytes.
    Yachnin S
    Nature; 1965 Jul; 207(996):536. PubMed ID: 5886150
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody.
    Rosse WF; Dacie JV
    J Clin Invest; 1966 May; 45(5):736-48. PubMed ID: 5935361
    [No Abstract]   [Full Text] [Related]  

  • 15. [Properdin and hemolysis; heparin inhibition of erythrocyte hemolysis in patients with paroxysmal nocturnal hemoglobinuria].
    FRITZSCHE W; MARTIN H
    Klin Wochenschr; 1957 Dec; 35(23):1166-8. PubMed ID: 13515159
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells.
    Logue GL; Rosse WF; Adams JP
    J Clin Invest; 1973 May; 52(5):1129-37. PubMed ID: 4700488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paroxysmal nocturnal hemoglobinuria, a clue disease.
    Hinz CF
    N Engl J Med; 1973 Oct; 289(14):744-5. PubMed ID: 4727533
    [No Abstract]   [Full Text] [Related]  

  • 18. COEXISTENT PAROXYSMAL NOCTURNAL AND COLD HEMOGLOBINURIA PRECEDED BY APLASTIC ANEMIA: A CASE REPORT AND FAMILY STUDY.
    MENGEL CE; HYMAN BN; O'MALLEY BW; HOWELL DA
    Blood; 1964 Oct; 24():451-7. PubMed ID: 14220787
    [No Abstract]   [Full Text] [Related]  

  • 19. [NOCTURNAL PAROXYSMAL HEMOGLOBINURIA: STUDIES IN VITRO AND IN VIVO ON THE SUSCEPTIBILITY OF HEMOLYSIS TO A MERCAPTANE COMPOUND (PENICILLAMINE)].
    VON FELTEN
    Acta Haematol; 1964 Sep; 32():168-82. PubMed ID: 14227136
    [No Abstract]   [Full Text] [Related]  

  • 20. A DONATH-LANDSTEINER ANTIBODY (NON-SYPHILITIC TYPE).
    WEINER W; GORDON EG; ROWE D
    Vox Sang; 1964; 9():684-97. PubMed ID: 14260783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.